Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits
Diabetes & Metabolism
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits. // Diabetes & Metabolism. – URL: https://www.sciencedirect.com/science/article/pii/S1262363626000728?dgcid=rss_sd_all
Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits. Diabetes & Metabolism. https://www.sciencedirect.com/science/article/pii/S1262363626000728?dgcid=rss_sd_all
“Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits.” Diabetes & Metabolism.
@article{article3279,
title = {Perioperative management of SGLT2 inhibitors: balancing euglycaemic ketoacidosis risk and cardiorenal benefits},
journal = {Diabetes \& Metabolism},
url = {https://www.sciencedirect.com/science/article/pii/S1262363626000728?dgcid=rss_sd_all}
}